A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Doses of Aplindore MR (1, 3, and 6 mg Twice Daily) in Patients with Early Parkinson Disease

Grant

Date/time Interval

  • March 25, 2009 - March 24, 2013
  • Total Award Amount

  • 73326.00
  • Direct Costs

  • 58196.00
  • Sponsor Award Id

  • APLINDORE
  • Contributor

  • Standaert, David   Principal Investigator